Table 1.
Patients Demographics and Baseline Characteristics
| Part 1 N=14 |
Part 2 N=32 |
All Patients N=46 |
|
|---|---|---|---|
| Age, years, mean (range) | 50.6 (26, 72) | 61.2 (36, 78) | 58 (26, 78) |
| Sex, n (%) | |||
| Female | 13 (92.9) | 27 (84.4) | 40 (87) |
| Male | 1 (7.1) | 5 (15.6) | 6 (13) |
| Race, n (%) | |||
| White | 13 (92.9) | 30 (93.8) | 43 (93.5) |
| Asian | 1 (7.1) | 1 (3.1) | 2 (4.3) |
| Black or African American | 0 | 1 (3.1) | 1 (2.2) |
| Ethnicity, n (%) | |||
| Hispanic or Latino | 2 (14.3) | 1 (3.1) | 3 (6.5) |
| Primary tumor type, n (%) | |||
| Ovarian | 8 (57.1) | 20 (62.5) | 28 (60.9) |
| SCLC | 1 (7.1) | 12 (37.5) | 13 (28.3)) |
| Cervical | 5 (35.7) | 0 | 5 (10.9) |
| Prior lines of therapy, mean (range) | |||
| Ovarian | 3.0 (2–4) | 3.2 (1–4) | 3.1 (1–4) |
| SCLC | 1.0 (1) | 1.5 (1–3) | 1.5 (1–3) |
| Cervical | 2.8 (1–4) | N/A | 2.8 (1–4) |
| ECOG stage, n (%) | |||
| 0 | 4 (28.6) | 13 (40.6) | 17 (37) |
| 1 | 10 (71.4) | 19 (59.4) | 29 (63) |